COVID-19 mass vaccination – an illustration of the impact of syringe choice on the effectiveness of mass vaccination campaigns

Roseline Mazet (1) , Luc Choisnard (2) , Julien Leenhardt (1) , Olivier Epaulard (1) , Etienne Brudieu (1) , Pierrick Bedouch (3, 1)

1 CHUGA - Centre Hospitalier Universitaire [CHU Grenoble]
2 UGA - Université Grenoble Alpes
3 TIMC-ThEMAS - Techniques pour l'Evaluation et la Modélisation des Actions de la Santé

In order to optimise the operational implementation of mass vaccination policies, it is critical to consider not only the supply of vaccines as well as each element of the vaccination process. This study, which was conducted in a vaccination center clearly shows how the choice of a syringe reference used during the COVID-19 vaccination campaign influences the number of vaccine doses available. The results appear to be closely related to the type of vaccine used (COMIRNATY® and SPIKEVAX®). In this context, the choice of the right reference of syringe has major economic and organisational consequences on a global scale.

Mots clés: Mass vaccination; Mass vaccination; COVID-19; medical device; public health; vaccination capacity

Domaines: Médicaments

Roseline Mazet, Luc Choisnard, Julien Leenhardt, Olivier Epaulard, Etienne Brudieu, et al.. COVID-19 mass vaccination – an illustration of the impact of syringe choice on the effectiveness of mass vaccination campaigns. Emerging microbes & infections, 2022, 11 (1), pp.804 - 806. ⟨10.1080/22221751.2022.2048968⟩. ⟨hal-04777009⟩